Esophageal Lichen Planus Is Associated With a Significant Increase in Risk of Squamous Cell Carcinoma.
Aged
Aged, 80 and over
Chemotherapy, Adjuvant
Deglutition Disorders
Disease Progression
Endoscopic Mucosal Resection
Endoscopy, Digestive System
Esophageal Diseases
/ drug therapy
Esophageal Neoplasms
/ epidemiology
Esophageal Squamous Cell Carcinoma
/ epidemiology
Esophagectomy
Female
Glucocorticoids
/ therapeutic use
Humans
Immunosuppressive Agents
/ therapeutic use
Lichen Planus
/ drug therapy
Male
Middle Aged
Radiotherapy, Adjuvant
Risk Factors
Journal
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
ISSN: 1542-7714
Titre abrégé: Clin Gastroenterol Hepatol
Pays: United States
ID NLM: 101160775
Informations de publication
Date de publication:
08 2019
08 2019
Historique:
received:
07
08
2018
revised:
09
10
2018
accepted:
11
10
2018
pubmed:
21
10
2018
medline:
29
10
2020
entrez:
21
10
2018
Statut:
ppublish
Résumé
Esophageal lichen planus (ELP) is a chronic inflammatory process characterized by apoptotic activity of cytotoxic CD8+ T cells on basal keratinocytes as well as regulatory and helper T cells.
Identifiants
pubmed: 30342260
pii: S1542-3565(18)31139-X
doi: 10.1016/j.cgh.2018.10.018
pii:
doi:
Substances chimiques
Glucocorticoids
0
Immunosuppressive Agents
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1902-1903.e1Informations de copyright
Copyright © 2019 AGA Institute. Published by Elsevier Inc. All rights reserved.